Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000145

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Dec 5, 2017
Accepted (ET)
Dec 12, 2017 · 7:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 5, 2017P3,000$0.0599A24,360,189D
Common StockDec 5, 2017P1,714$0.0584A24,361,903D
Common StockDec 5, 2017P1,286$0.059A24,363,189D
Common StockDec 5, 2017P3,000$0.0588A24,366,189D
Common StockDec 5, 2017P3,000$0.0596A24,369,189D
Common StockDec 5, 2017P3,000$0.059A24,372,189D
Common StockDec 6, 2017P3,000$0.0559A24,375,189D
Common StockDec 6, 2017P3,000$0.0558A24,378,189D
Common StockDec 6, 2017P3,000$0.052A24,381,189D
Common StockDec 6, 2017P3,000$0.055A24,384,189D
Common StockDec 6, 2017P3,000$0.0545A24,387,189D
Common StockDec 6, 2017P5,000$0.055A24,392,189D
Common StockDec 6, 2017P3,000$0.055A24,395,189D
Common StockDec 6, 2017P3,000$0.055A24,398,189D
Common StockDec 6, 2017P5,000$0.05A24,403,189D
Common StockDec 6, 2017P5,000$0.05A24,408,189D
Common StockDec 6, 2017P3,000$0.05A24,411,189D
Common StockDec 6, 2017P3,000$0.05A24,414,189D
Common StockDec 6, 2017P5,000$0.05A24,419,189D
Common StockDec 6, 2017P3,000$0.055A24,422,189D
Common StockDec 6, 2017P3,000$0.055A24,425,189D
Common StockDec 6, 2017P5,000$0.055A24,430,189D
Common StockDec 6, 2017P3,000$0.055A24,433,189D
Common StockDec 6, 2017P3,000$0.055A24,436,189D
Common StockDec 6, 2017P3,000$0.06A24,439,189D

Table II — derivative securities

No Table II lines on this filing.